About RTK Group
RTK Group is a seed-stage biopharmaceutical advisory and investment fund focused on emerging technologies having disruptive impact and significant potential to benefit patients. It focuses its efforts where it can leverage its expertise in company formation and technology development to assist high-performing management teams realize the full value potential of their technology. The firm was founded in 2019 and is based in Boston, Massachusetts.
Want to inform investors similar to RTK Group about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
RTK Group Investments
RTK Group has made 1 investments. Their latest investment was in Unravel Biosciences as part of their Seed VC on June 6, 2022.
RTK Group Investments Activity
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.